SCHEMBL2956697

SCHEMBL2956697

CCCCc1csc([P])c1CCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TYR P14679 3/20 0.36
GPR35 Q9HC97 5/20 0.36
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
LIPG Q9Y5X9 1/20 0.32
MAPT P10636 2/20 0.31
CYP3A4 P08684 2/20 0.31
MTNR1A P48039 1/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
ALOX5 P09917 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2967055 0.83 HMGCR (0.31)
SCHEMBL2754799 0.79 HTT (0.36) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL8564899 0.78 HTT (0.35) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2754801 0.77 NPC1 (0.36) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL16976520 0.76 SKP2 (0.35) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2975960 0.76 NPC1 (0.34) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2754800 0.74 NPC1 (0.33) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2754798 0.73 NPC1 (0.32) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL27284452 0.73 IKBKB (0.40) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2754793 0.72 GPR35 (0.36) HTTNPC1HPGDMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL HTT 4838/4885NPC1 4195/4885HPGD 4608/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 HTT 3857/4885NPC1 4083/4885HPGD 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.